| 1NCI.Director’s challenge:toward a molecular classification of tumors[EB/OL].http:∥grauts.nih.Gov/grauts/guide/rfa-files/RFA-CA-98-027.html.
2Golub TR,Slonim DK,Tamayo P,et al.Molecular classification of cancer:class discovery and class prediction by gene expression monitoring[J].Science,1999,286(5439):531-537.
3Dalton R,Abbott A.Can researchers find recipe for proteins and chips[J].Na-ture,1999,402(6763):718-719.
4Perez-Eneiso M,Tenenhans M.Prediction of clinical outcome with microarray data:a partial least squares discriminant analysis(PLS—DA)approach[J].Hum Gen-et,2003,112(56):581-592.
5Mockler TC,Chan S,Sundaresan A,et al.Applications of DNA tiling arrays for whole-genome analysis[J].Genomics,2005,85(5):655.
6Bhattacharjee A,Richards WG,Staunton J,et al.Classification of human lung car-cinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses[J].Proc Natl Acad Sci USA,2001,98(24):13790-13795.
7Garber ME,Troyanskaya OG,Schluens K,et al.Diversity of gene expression in ad-enocarcinoma of the lung[J].Proc Natl Acad Sci USA,2001,98(24):13784-13789.
8Hayes DN,Monti S,Parmigiani G,etal.Gene expression profilingeveals reproduci-ble human lung adenocarcinoma subtypes in multiple independent patient cohorts[J].Journal of Clinical Oncology,2006,24(31):5079-5090.
9Potti A,Mukherjee S,Petersen R,et al.A genomic strategy to refine prognosis in early-stage non-small-cell lung cancer[J].N Engl J Med,2006,355(6):570-580.
10Zhukov TA,Johanson RA,Cantor AB,et al.Discovery of distinct protein profiles specific for lung tumors and pre-malignant lung lesions by SELD Imass spectrom-etry[J].Lung Cancer,2003,40(3):267-279.
11Tan D,Deeb G,Wang J,et al.Her-2/neu protein expression and gene alteration in stage I-IIIA non-small-cell lung cancer:a study of140cases using a combina-tion of high throughput tissue microarray,immunohist-ochemistry,and fluorescent in situhybridi-zation[J].Diagn Mol Pathol,2003,12(4):201-211.
12乔贵宾,吴一龙,区伟,等.免疫组化方法检测肿瘤标志在肺癌组织芯片中表达的可靠性研究[J].肿瘤防治研究,2004,31(8):467-470.
13Sugtia M,Geraci M,Gao B,et al.Combined use of oligonucleotide and tissue mi-croarrays identifies cancer/testis antigens as biomarkers in lung carcinoma[J].Cancer Res,2002,62(9):3971.
14D’Amico TA,Massey M,Herndon JE,et al.Abiologic risk model for stage I lung cancer:immunohisto chemical analysis of408patients with the use of ten molecu-lar markers[J].J Thorac Cardiovasc Surg.1999,117(4):36.
15Kwiatkowski DJ,Harpole DH,Godleski J,etal.Molecular pathologic substagingin244stage I non-small-cell lung cancer patients:clinical implications[J].J Clin Oncol,1998,16(7):2468. |
